Search results
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
The New York Times via Yahoo News· 20 minutes agoAmericans are paying too much for prescription drugs. It is a common, long-standing complaint. And...
OncoBeta introduces Rhenium-SCT for non-melanoma skin cancer patients at Hospital Universitario 12...
Digital Journal· 1 day agoJun. 20, 2024 / PRZen / MADRID -- OncoBeta®, a leading medical device company specialising in innovative epidermal radioisotope therapies, today announced Hospital Universitario 12 de Octubre ...
Ultrasensitive liquid biopsy tech spots cancer earlier than standard methods | Cornell Chronicle
Cornell News Service· 3 days agoThe new technology has the potential to improve cancer care with the very early detection of...
Acute myeloid leukemia discovery tackles drug-resi | Newswise
Newswise· 1 day agoIndiana University School of Medicine researchers and their collaborators have uncovered molecular...
As big pharma exits Nigeria, asthma patients face spiralling costs
Al Jazeera· 2 days agoWhen Gloria Mofifoluwa’s friend informed her in March that the price of inhalers had risen in...
King honours doctor in charge of his cancer treatment
Daily Telegraph· 7 days agoWhen it shut down in 2010 amid a fraud scandal, Dr Dixon co-founded the College of Medicine and...
Combination targeted treatment produces lasting remissions in people with resistant aggressive...
Science Daily· 2 days agoIn a clinical trial at NIH's National Cancer Institute, researchers tested the combination of venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (called ViPOR ...
New screening tool could improve the survival rate of patients with hepatocellular carcinoma from...
Medical Xpress· 4 days agoEarly diagnosis of hepatocellular carcinoma (HCC)—one of the most fatal malignancies—is crucial to improve patient survival. This important screening tool may increase the ...
Vonoprazan Relieves Heartburn in NERD as Early as Day One
Medscape· 1 day agoVonoprazan reduced heartburn symptoms in patients with nonerosive reflux disease as early as the...
FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL...
Morningstar· 7 days agoAmgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved BLINCYTO® (blinatumomab) for the treatment of adult and pediatric patients one ...